Your Counselling Ltd., a leading provider of mental health and counselling services, is proud to announce the launch of two new community-focused initiatives designed to make mental health support ...

Bank of America Corporation (NYSE:BAC) is one of the Most Undervalued S&P 500 Stocks to Buy Right Now. On September 4, Bank of America Corporation’s (NYSE:BAC) Bank of America Private Bank and Merrill ...

INDIANAPOLIS (WISH) — Indiana has become a global hub for artificial intelligence empowerment with the launch of the Hoosier AI 1000 program, aimed at expanding AI access and training. Emil Ekiyor, ...

“Our government is protecting our long-term care system with targeted investments that ensure people get the right care in the right place,” said Natalia Kusendova-Bashta, Minister of Long-Term Care. ...

RESEARCH TRIANGLE PARK, N.C, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologically derived therapeutics, announced the enrollment of the 30 ...

In other immigration news, Bloomberg is reporting ICE is about to get access to a controversial spyware program built by the Israeli-based company Paragon. A $2 million contract was signed last year, ...

Labrador MHAs Lisa Dempster and Perry Trimper (centre) attended an announcement regarding the Liberals’ new Labrador Air Access Pilot Program at the airport in Happy Valley-Goose Bay on Aug. 28. 2025.

The provincial government’s new pilot program intended to make air travel more affordable for Labrador residents “doesn’t go far enough to address the needs of Labrador Inuit communities,” Nunatsiavut ...

As the challenges mount to pursue a college education, including funding, Southeast Missouri State University aims to make the process easier for all students who choose to attend. On a bright sunny ...

On Wednesday Premier John Hogan announced a $2 million year-long pilot project to publicly fund some nurse practitioners. (Have a Nice Day Photo/Shutterstock) Newfoundland and Labrador is launching a ...

Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on primary or secondary endpoints in a rare neurodegenerative disease, prompting the company to discontinue the program. Oral ...